Usher syndrome, type 1
Other Names: USH1A; Usher syndrome, type 1A; Usher syndrome, type I, French variety; Retinitis pigmentosa and congenital deafness; USH1; US1 Usher syndrome is a genetic disorder characterized by sensorineural hearing loss or deafness and progressive vision loss due to retinitis pigmentosa. Sensorineural hearing means it is caused by abnormalities of the inner ear. Retinitis pigmentosa is an eye disease that affects the layer of light-sensitive tissue at the back of the eye (the retina). Vision loss occurs as the light-sensing cells of the retina gradually deteriorate. Night vision loss begins first, followed by blind spots that develop in the side (peripheral) vision, that can enlarge and merge to produce tunnel vision (loss of all peripheral vision). In some cases, vision is further impaired by clouding of the lens of the eye (cataracts).
Epidemiology
Usher syndrome affects approximately 4 to 17 per 100,000 people,1,2 and accounts for about 50 percent of all hereditary deaf-blindness cases.3 The condition is thought to account for 3 to 6 percent of all children who are deaf, and another 3 to 6 percent of children who are hard-of-hearing.
Cause
So far, researchers have found nine genes that cause Usher syndrome. Type 1 Usher syndrome: MY07A, USH1C, CDH23, PCHD15, USH1G
Inheritance
Usher syndrome is inherited, which means that it is passed from parents to a child through genes. Each person inherits two copies of a gene, one from each parent. Sometimes genes are altered, or mutated. Mutated genes may cause cells to develop or act abnormally.
Usher syndrome is inherited as an autosomal recessive disorder. “Autosomal” means that men and women are equally likely to have the disorder and equally likely to pass it on to a child of either sex. “Recessive” means that the condition occurs only when a child inherits two copies of the same faulty gene, one from each parent. A person with one abnormal Usher gene does not have the disorder but is a carrier who has a 50 percent chance of passing on the abnormal gene to each child. When two carriers with the same mutated Usher syndrome gene have a child together, each birth
Signs and symptoms
Children with type 1 Usher syndrome have profound hearing loss or deafness at birth and have severe balance problems. Many obtain little or no benefit from hearing aids but may be candidates for a cochlear implant—an electronic device that can provide a sense of sound to people with severe hearing loss or deafness. (For more information, read the NIDCD fact sheet Cochlear Implants.) Parents should consult with their child’s doctor and other hearing health professionals early to determine communication options for their child. Intervention should begin promptly, when the brain is most receptive to learning language, whether spoken or signed.
Balance problems associated with type 1 Usher syndrome delay sitting up without support. Walking rarely occurs prior to 18 months. Vision problems with type 1 Usher syndrome usually begin before age 10, starting with difficulty seeing at night and progressing to severe vision loss over several decades.
For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms
- Abnormal cochlea morphology
- Abnormal electroretinogram
- Ataxia
- Global developmental delay
- Hemianopia
- Intellectual disability(Mental deficiency)
- Iris hypopigmentation(Light eye color)
- Nyctalopia(Night blindness)
- Scotoma
- Sensorineural hearing impairment
- Vestibular hypofunction
- Visual loss(Loss of vision)
30%-79% of people have these symptoms
- Aplasia/Hypoplasia of the cerebellum(Absent/small cerebellum)
- Cataract(Clouding of the lens of the eye)
- High hypermetropia(Severe farsightedness)
- Schizophrenia
5%-29% of people have these symptoms
- Abnormality of dental enamel(Abnormal tooth enamel)
- Anxiety(Excessive, persistent worry and fear)
- Cerebral cortical atrophy(Decrease in size of the outer layer of the brain due to loss of brain cells)
- Depressivity(Depression)
- Hallucinations(Hallucination)
- Subcortical cerebral atrophy
Diagnosis
Diagnosis of Usher syndrome involves pertinent questions regarding the person’s medical history and testing of hearing, balance, and vision. Early diagnosis is important, as it improves treatment success. An eye care specialist can use dilating drops to examine the retina for signs of RP. Visual field testing measures peripheral vision.
An electroretinogram [e-lec-tro-RET-in-o-gram] measures the electrical response of the eye’s light-sensitive cells in the retina. Optical coherence tomography may be helpful to assess for macular cystic changes.
Videonystagmography [vi-de-o-nigh-stag-MAH-gra-fee] measures involuntary eye movements that could signify a balance problem. Audiology testing determines hearing sensitivity at a range of frequencies.
Genetic testing may help in diagnosing Usher syndrome. So far, researchers have found nine genes that cause Usher syndrome. Genetic testing is available for all of them:
Type 1 Usher syndrome: MY07A, USH1C, CDH23, PCHD15, USH1G
Treatment
In infants: an initial trial of hearing aids to stimulate residual hearing and accustom the infant to auditory stimulation. Cochlear implantation should be considered as young as medically feasible. Sign language and tactile signs (once visual loss occurs) for families who choose non-auditory communication.
Specialized training from educators of the hearing impaired. Vestibular compensation therapy for children with residual balance function and sensory substitution therapy for individuals with complete absence of vestibular function. Standard treatments for retinitis pigmentosa.
| Disorders of hearing and balance | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NIH genetic and rare disease info
Usher syndrome, type 1 is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Usher syndrome, type 1
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Deepika vegiraju